Home
NICE Guidance
Published Guidance

The clinical effectiveness and cost effectiveness of new drugs for bipolar disorder

Technology appraisal guidance [TA66] Published date: 24 September 2003

Guidance

This guidance has been updated and replaced NICE guideline CG38.